The Company has informed that the board of directors approved, subject to the approval of the shareholders, the offer of RAK Pharmaceuticals Pvt. Ltd. to settle the long outstanding loan given by the Company of an amount of BDT 500,000,000 and interest of BDT 334,665,468 thereof as on February 18, 2015 totaling to BDT 834,665,468 in consideration of the final settlement of an amount of BDT 44,118,000 in cash (cont.-1)